Аптеки 36.6 APTK

Аптеки 36.6 Financial Ratios 2025-2004 | APTK

Brief overview of Аптеки 36.6's valuation and returns

Current figures are compared with the company's own five-year history for 2006–2025.

Market valuation is represented by P/E 246x (median 118x), EV/EBITDA 5x (median 11.49x), P/S 0.61x (median 1.5x). On average, multiples differ from their five-year medians by only -5.4%. Valuation is near its familiar historical range.

The inverse P/E implies an earnings yield of 0.4%. This is not a dividend yield, but current earnings relative to market price.

Current measures of operating quality are ROE -3.6%, ROA 0.4%, ROCE -2.6%. Returns below zero mean resources are not producing positive profit. Recovery in operating results is the main reference point.

Short-term solvency needs attention at ratios of 0.54x and 0.23x.

The cash conversion cycle shortened from -26.9 days to -56.9 days, or 30 days. Working capital returns faster.

Overall assessment

Аптеки 36.6's market valuation is near its own historical norm, while quality ratios provide no extreme signal.

Annual Financial Ratios Аптеки 36.6

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Price Earnings Ratio, P/E	246	101	118	395.89	-111.65	-96.4	-6.91	-0.53	-1.75	-1.26	-94.65	-120.89	-0.24	-4.18	-4.71	-6.12	-645.39	-139.19	-77.84	0.46	1.83	13.53
Price Sales Ratio, P/S	0.61	1	2	1.5	2.4	2.44	1.33	0.27	0.47	0.26	0.53	0.73	0.21	0.19	0.23	0.28	11.01	7.55	11.17	0.03	0.05	0.07
Price To Book Ratio, P/B	-2	-3	-5	-13.73	-15.94	-16.77	-2.6	-0.33	-1.66	-22.26	12.15	-18.79	-0.23	18.94	4.08	2.63	106.58	883.68	124.55	0.18	0.31	0.37
Price Earnings To Growth Ratio, PEG	10559	-	-	-3.18	5.58	1.05	0.08	-0.01	0.04	-0.0	-1.74	1.21	-0.0	0.69	-0.81	-0.0	8.24	3.14	0.77	0.0	0.0	-
Operating Cash Flow Per Share	0.66	0.85	0.92	0.86	0.42	-0.49	-0.36	-3.87	-4.22	-3.04	3.59	-0.33	-28.79	6.42	-0.01	-16.11	-0.49	0.08	-0.16	-131.41	-42.4	18.99
Free Cash Flow Per Share	-0.05	0.06	0.25	0.73	0.29	-0.78	-0.76	-4.21	-4.4	-3.43	-0.71	-1.03	-29.55	-4.35	-7.12	-19.37	-0.53	-0.01	-0.36	-224.84	-103.37	-19.28
Cash Per Share	0.18	0.26	0.27	0.11	0.23	-0.06	0.17	0.21	0.25	0.51	0.27	0.36	3.88	6.65	9.28	8.53	0.15	0.14	0.17	37.73	24.97	5.09
Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Yield	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	-	-	-	0.54	0.47	1.23	0.54	0.3	0.63	0.47	0.7	0.77	0.33	0.82	0.82	1.32	1.12	0.76	0.65	1.2	1.29	0.64
Quick Ratio	-	-	-	0.23	0.25	1.02	0.25	0.11	0.32	0.19	0.36	0.37	0.12	0.6	0.61	0.81	0.69	0.47	0.34	0.63	0.76	0.37
Cash Ratio	-	-	-	0.03	0.06	0.04	0.03	0.01	0.03	0.02	0.02	0.02	0.06	0.05	0.06	0.13	0.09	0.06	0.06	0.07	0.09	0.01
Days Of Sales Outstanding, DSO	-	-	-	-	40.61	-	17.97	12.5	30.36	16.44	18.34	111.85	10.33	123.51	144.6	-	81.41	57.09	-	75.39	75.13	65.04
Days Of Inventory Outstanding, DIO	-	-	-	80.59	80.2	74.31	83.65	66.59	76.28	78.0	71.14	255.17	69.75	92.84	100.8	122.2	98.83	60.24	106.22	115.66	98.3	82.31
Days Of Payables Outstanding, DPO	-	-	-	137.52	138.03	114.66	144.74	105.97	178.11	216.98	174.07	467.25	160.61	160.87	164.4	100.99	109.8	109.89	123.42	114.86	104.03	80.33
Operating Cycle	-	-	-	80.59	120.81	74.31	101.61	79.09	106.64	94.44	89.48	367.02	80.08	216.35	245.41	122.2	180.24	117.33	106.22	191.05	173.43	147.35
Cash Conversion Cycle	-	-	-	-56.93	-17.22	-40.35	-43.12	-26.88	-71.47	-122.54	-84.59	-100.23	-80.53	55.48	81.0	21.21	70.44	7.44	-17.19	76.19	69.4	67.03
Gross Profit Margin	-	-	-	0.34	0.34	0.35	0.28	0.13	0.22	0.21	0.28	0.29	0.25	0.36	0.45	0.41	0.39	0.34	0.3	0.35	0.39	0.38
Operating Profit Margin	0.09	0.08	0.06	0.08	0.01	0.02	-0.02	-0.09	-0.08	-0.11	-0.01	0.04	-0.66	0.11	0.08	0.06	0.04	-0.01	-0.07	0.02	0.05	0.05
Pretax Profit Margin	0.0	0.01	0.01	0.01	-0.03	-0.02	-0.19	-0.51	-0.27	-0.2	-0.04	-0.03	-0.83	0.05	-0.0	-0.0	0.01	-0.06	-0.12	0.1	0.04	0.02
Net Profit Margin	0.0	0.01	0.01	0.0	-0.02	-0.03	-0.19	-0.51	-0.27	-0.2	-0.01	-0.01	-0.87	-0.05	-0.05	-0.05	-0.02	-0.05	-0.14	0.07	0.03	0.01
Effective Tax Rate	-	-	-	0.46	-0.34	-0.54	-0.01	-0.01	0.0	0.01	0.13	0.66	-0.02	0.2	-11.52	-10.06	0.83	-0.22	-0.09	0.19	0.33	0.74
Return On Assets, ROA	0.0	0.01	0.02	0.01	-0.03	-0.02	-0.27	-0.7	-0.33	-0.21	-0.01	-0.0	-2.74	-0.04	-0.05	-0.05	-0.02	-0.1	-0.15	0.07	0.03	0.01
Return On Equity, ROE	-0.04	-0.12	-0.14	-0.03	0.14	0.17	0.38	0.62	0.95	17.6	-0.13	0.16	0.97	-4.54	-0.87	-0.43	-0.17	-6.35	-1.6	0.4	0.17	0.03
Return On Capital Employed, ROCE	-2.62	-1.65	-1.29	0.3	0.06	0.03	-0.13	1.0	-0.26	-0.31	-0.03	0.1	1.88	0.36	0.3	0.12	0.09	-0.07	-0.22	0.04	0.1	0.19
Net Income Per Ebt	1.0	1.0	1.0	0.54	0.66	1.54	1.01	1.01	1.0	0.99	0.13	0.2	1.05	-0.89	44.96	23.77	-2.32	0.94	1.2	0.67	0.61	0.28
Ebt Per Ebit	0.03	0.13	0.22	0.09	-2.86	-0.81	10.9	5.56	3.47	1.82	3.47	-0.69	1.27	0.47	-0.01	-0.03	0.18	4.39	1.79	4.12	0.9	0.35
Ebit Per Revenue	0.09	0.08	0.06	0.08	0.01	0.02	-0.02	-0.09	-0.08	-0.11	-0.01	0.04	-0.66	0.11	0.08	0.06	0.04	-0.01	-0.07	0.02	0.05	0.05
Debt Ratio	1.42	1.45	1.45	0.74	0.83	0.91	1.24	1.69	0.81	0.45	0.48	0.38	2.25	0.49	0.44	0.67	0.43	0.26	0.36	0.48	0.45	0.47
Debt Equity Ratio	-0.86	-0.85	-0.86	-5.05	-4.71	-8.72	-1.72	-1.5	-2.33	-38.21	9.52	-16.83	-0.8	50.98	8.01	5.86	3.43	16.99	3.89	2.86	2.27	1.93
Long Term Debt To Capitalization	-6.11	-5.63	-6.27	1.98	2.99	1.23	8.61	-2.92	1.95	1.03	0.9	1.11	-1.51	0.92	0.57	0.73	0.68	0.75	0.21	0.68	0.63	0.15
Total Debt To Capitalization	-6.11	-5.63	-6.27	1.25	1.27	1.13	2.38	3.0	1.75	1.03	0.9	1.06	-4.01	0.98	0.89	0.85	0.77	0.94	0.8	0.74	0.69	0.66
Interest Coverage	2.0	1.71	1.75	1.13	-	0.17	-0.15	-0.64	-1.07	-2.06	-0.19	0.64	-5.28	1.58	1.24	1.0	0.75	-0.37	-1.47	0.74	1.0	1.41
Cash Flow To Debt Ratio	0.22	0.28	0.34	0.2	0.1	-0.07	-0.04	-0.17	-0.35	-0.17	0.29	-0.03	-0.42	0.07	-0.0	-0.15	-0.32	0.08	-0.11	-0.18	-0.12	0.08
Company Equity Multiplier	-2.37	-2.24	-2.22	-6.78	-5.69	-9.54	-1.38	-0.89	-2.89	-84.3	19.69	-43.99	-0.36	103.93	18.3	8.7	7.93	65.92	10.69	5.95	5.06	4.09
Receivables Turnover	-	-	-	-	8.99	-	20.31	29.19	12.02	22.2	19.91	3.26	35.34	2.96	2.52	-	4.48	6.39	-	4.84	4.86	5.61
Payables Turnover	-	-	-	2.65	2.64	3.18	2.52	3.44	2.05	1.68	2.1	0.78	2.27	2.27	2.22	3.61	3.32	3.32	2.96	3.18	3.51	4.54
Inventory Turn Over	-	-	-	4.53	4.55	4.91	4.36	5.48	4.79	4.68	5.13	1.43	5.23	3.93	3.62	2.99	3.69	6.06	3.44	3.16	3.71	4.43
Fixed Asset Turnover	-	-	-	4.03	4.04	3.5	5.41	81.06	61.78	44.78	31.76	12.04	11.69	5.54	6.55	7.13	7.0	9.21	4.51	4.7	3.55	2.92
Asset Turnover	1.65	1.43	1.27	1.35	1.17	0.72	1.41	1.37	1.21	1.03	1.17	0.59	3.14	0.94	0.99	1.09	1.22	1.78	1.04	1.04	1.23	1.28
Operating Cash Flow Sales Ratio	0.05	0.07	0.1	0.11	0.07	-0.09	-0.04	-0.21	-0.23	-0.08	0.12	-0.02	-0.3	0.04	-0.0	-0.09	-0.11	0.01	-0.04	-0.08	-0.04	0.03
Free Cash Flow Operating Cash Flow Ratio	0.63	0.77	0.82	0.84	0.7	1.57	2.13	1.09	1.04	1.13	-0.2	3.16	1.03	-0.68	897	1.2	1.09	-0.09	2.22	1.71	2.44	-1.02
Cash Flow Coverage Ratios	0.22	0.28	0.34	0.2	0.1	-0.07	-0.04	-0.17	-0.35	-0.17	0.29	-0.03	-0.42	0.07	-0.0	-0.15	-0.32	0.08	-0.11	-0.18	-0.12	0.08
Short Term Coverage Ratios	-	-	-	1.11	0.28	-0.33	-0.27	-0.5	-2.92	-1.1	4.27	-0.08	-1.71	0.1	-0.0	-0.54	-0.85	0.11	-0.12	-0.68	-0.48	0.08
Capital Expenditure Coverage Ratio	2.71	4.3	5.51	6.37	3.29	-1.75	-0.88	-11.19	-24.26	-7.81	0.83	-0.46	-37.79	0.6	-0.0	-4.93	-11.37	0.92	-0.82	-1.41	-0.7	0.5
Dividend Paid And Capex Coverage Ratio	2.71	4.3	5.51	6.37	3.29	-1.75	-0.88	-11.19	-24.26	-7.81	0.83	-0.46	-37.79	0.6	-0.0	-4.93	-11.37	0.92	-0.82	-1.41	-0.7	0.5
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Price To Free Cash Flows Ratio, P/FCF	20.25	17.61	18.8	15.88	47.22	-18.08	-16.09	-1.21	-1.98	-3.01	-22.31	-12.37	-0.66	-7.4	-5.43	-2.45	-89.7	-6873.68	-131.02	-0.21	-0.46	-2.46
Price To Operating Cash Flows Ratio, P/OCF	12.78	13.51	15.39	13.39	32.87	-28.41	-34.3	-1.31	-2.06	-3.39	4.43	-39.05	-0.68	5.01	-4874.35	-2.95	-97.58	612.64	-291.22	-0.36	-1.12	2.5
Price Cash Flow Ratio, P/CF	12.78	13.51	15.39	13.39	32.87	-28.41	-34.3	-1.31	-2.06	-3.39	4.43	-39.05	-0.68	5.01	-4874.35	-2.95	-97.58	612.64	-291.22	-0.36	-1.12	2.5
Enterprise Value Multiple, EV	5	8	22	11.49	63.69	14.84	82.7	-6.67	-7.34	-5.84	726.12	28.82	-1.29	4.74	6.8	9.96	131.88	496.41	-280.88	3.05	3.26	4.8
Price Fair Value, P/FV	-2	-3	-5	-13.73	-15.94	-16.77	-2.6	-0.33	-1.66	-22.26	12.15	-18.79	-0.23	18.94	4.08	2.63	106.58	883.68	124.55	0.18	0.31	0.37

All numbers in RUB currency

Quarterly Financial Ratios Аптеки 36.6

	2023-Q2	2022-Q4	2021-Q4	2021-Q2	2020-Q4	2020-Q2	2019-Q4	2019-Q2	2018-Q4	2018-Q2	2017-Q4	2017-Q2	2016-Q4	2016-Q2	2015-Q4	2015-Q2	2014-Q4	2014-Q2	2013-Q4	2013-Q2	2012-Q4	2012-Q2	2011-Q4	2010-Q4	2010-Q2	2009-Q4	2009-Q2	2008-Q4	2008-Q2	2007-Q4	2007-Q2	2006-Q4	2006-Q2	2005-Q4	2005-Q2
Price Earnings Ratio, P/E	296	-	77.8	-20.6	109	-10.3	-4.13	-2.36	-0.169	-0.625	-0.477	-2.14	-0.289	86.1	-8.82	12.9	-	-0.936	-0.118	-0.135	53.3	-	-	-3.06	-3.06	-323	-323	-69.6	-69.6	-38.9	-38.9	0.229	0.229	0.915	0.915
Price Sales Ratio, P/S	3.38	-	4.56	5.1	8.39	3.69	3.34	1.7	0.537	0.609	0.792	0.937	0.466	0.501	0.976	0.827	-	0.14	0.412	0.471	0.887	-	-	0.558	0.558	22	22	15.1	15.1	22.3	22.3	0.06	0.06	0.1	0.1
Price To Book Ratio, P/B	-15.5	-	-15.9	-15.2	-18.8	-3.77	-3.57	-1.92	-0.322	-0.729	-1.47	817	-20.4	2.96	11.1	4.94	-	-0.134	-0.237	-3.15	37.9	-	-	2.63	2.62	107	190	884	218	125	111	0.185	0.231	0.309	0.338
Price Earnings To Growth Ratio, PEG	-	-	-0.601	0.033	-0.993	0.195	0.106	0.028	-0.001	0.013	-0.001	0.024	0.0	-0.802	0.033	-	-	0.01	-	0.0	-	-	-	-	-0.0	-	4.12	-	1.61	-	0.387	-	0.001	-	0.001
Operating Cash Flow Per Share	0.0	-	-	-0.1	0.267	-0.79	0.282	-1.19	-1.53	-2.42	-2.03	-2.75	-1.93	-1.49	3.66	0.292	-	-16.3	-33.1	4.27	1.52	-	-	-8.05	-8.05	-0.243	-0.243	0.039	0.039	-0.082	-0.082	-65.7	-65.7	-21.2	-21.2
Free Cash Flow Per Share	0.0	-	-	-0.144	0.219	-1.02	0.065	-1.36	-1.73	-2.49	-2.14	-2.79	-2.13	-1.66	3.47	0.292	-	-16.4	-31.8	2.26	-1.0	-	-	-9.69	-9.69	-0.265	-0.265	-0.003	-0.003	-0.181	-0.181	-112	-112	-51.7	-51.7
Cash Per Share	0.068	-	0.226	0.239	-0.054	0.194	0.124	0.135	0.216	0.306	0.283	0.136	0.557	0.304	0.293	0.806	-	2.12	3.88	5.71	3.32	-	-	8.53	7.34	0.151	0.148	0.145	0.155	0.165	0.118	37.7	31.4	25	15
Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividend Yield	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.516	0.537	0.467	0.704	1.23	0.759	0.543	0.468	0.3	0.512	0.627	0.635	0.471	1.03	0.702	0.758	0.768	0.392	0.335	0.846	0.815	0.833	0.821	1.32	1.22	1.12	0.908	0.76	0.699	0.649	0.802	1.2	1.23	1.29	0.942
Quick Ratio	0.18	0.23	0.246	0.323	1.02	0.395	0.255	0.197	0.113	0.239	0.319	0.284	0.216	0.625	0.378	0.358	0.373	0.16	0.074	0.645	0.601	0.615	0.614	0.814	0.75	0.685	0.557	0.469	0.398	0.34	0.421	0.635	0.675	0.755	0.546
Cash Ratio	0.02	0.029	0.06	0.11	0.041	0.054	0.032	0.016	0.014	0.026	0.026	0.014	0.021	0.012	0.022	0.045	0.016	0.033	0.062	0.052	0.053	0.036	0.056	0.128	0.111	0.093	0.075	0.062	0.06	0.059	0.061	0.065	0.072	0.085	0.048
Days Of Sales Outstanding, DSO	-	-	19	11.1	-	7.82	8.1	6.94	12.2	16	14.1	18.3	8.01	57.5	9.13	11.6	-	0.651	1.16	65.7	-	-	-0.061	-	20.7	40.1	40.6	28.2	14.1	-	12.9	37.2	29.7	37.1	29.8
Days Of Inventory Outstanding, DIO	38.4	-	37.6	37.5	48.1	33.3	32.9	36.8	37.9	39.1	34.6	43.9	33.9	56.7	32.1	53.2	-	17.7	41.8	56.3	51.8	50.6	95.9	60.3	56.1	48.7	47.8	29.7	33.8	52.4	44.6	57	42.2	48.5	38.5
Days Of Payables Outstanding, DPO	58.1	-	62.5	50	74.2	37.3	60	53.8	62	65.2	81.7	87.8	103	126	82.7	102	-	34.7	89.4	121	89.7	97.5	156	49.8	53.8	54.1	69.9	54.2	49.1	60.9	48.7	56.6	42.8	51.3	39.6
Operating Cycle	38.4	-	56.6	48.6	48.1	41.2	41	43.8	50.1	55.1	48.8	62.2	41.9	114	41.2	64.8	-	18.3	42.9	122	51.8	50.6	95.8	60.3	76.8	88.9	88.4	57.9	47.9	52.4	57.4	94.2	71.9	85.5	68.2
Cash Conversion Cycle	-19.7	-	-5.92	-1.42	-26.1	3.86	-19	-10.1	-11.8	-10.2	-32.9	-25.6	-60.9	-11.4	-41.5	-36.8	-	-16.4	-46.4	1.15	-37.9	-46.9	-60.6	10.5	23.1	34.7	18.6	3.67	-1.23	-8.48	8.75	37.6	29.1	34.2	28.7
Gross Profit Margin	0.331	-	0.341	0.337	0.233	0.21	0.18	0.164	0.258	0.234	0.213	0.295	0.19	0.275	0.241	0.327	-	0.263	0.251	0.251	0.354	0.422	0.476	0.412	0.412	0.394	0.394	0.344	0.344	0.298	0.298	0.347	0.347	0.386	0.386
Operating Profit Margin	0.174	-	-0.115	0.152	0.034	0.029	-0.011	-0.042	-0.105	-0.076	-0.139	-0.044	-0.243	0.029	-0.093	0.067	-	-0.014	-0.655	-0.655	-0.002	0.072	0.139	0.062	0.062	0.042	0.042	-0.013	-0.013	-0.067	-0.067	0.024	0.024	0.049	0.049
Pretax Profit Margin	0.005	-	-0.008	-0.06	0.117	-0.081	-0.199	-0.179	-0.782	-0.243	-0.417	-0.109	-0.401	-0.003	-0.106	0.022	-	-0.038	-0.83	-0.83	-0.092	0.027	0.061	-0.002	-0.002	0.007	0.007	-0.058	-0.058	-0.12	-0.12	0.098	0.098	0.045	0.045
Net Profit Margin	0.003	-	0.015	-0.062	0.019	-0.09	-0.202	-0.18	-0.792	-0.244	-0.415	-0.109	-0.403	0.001	-0.028	0.016	-	-0.037	-0.873	-0.873	0.004	-0.038	-0.082	-0.046	-0.046	-0.017	-0.017	-0.054	-0.054	-0.144	-0.144	0.065	0.065	0.027	0.027
Effective Tax Rate	0.453	-	-2.46	-0.028	0.072	-0.113	-0.017	-0.007	-0.012	-0.003	-0.006	-0.008	-0.005	-1.46	-0.017	0.406	-	-0.007	-0.017	-0.017	-0.165	0.986	0.265	-10.1	-10.1	0.835	0.835	-0.215	-0.215	-0.092	-0.092	0.19	0.19	0.332	0.332
Return On Assets, ROA	0.002	-	0.009	-0.037	0.005	-0.067	-0.156	-0.113	-0.534	-0.148	-0.266	-0.055	-0.21	0.001	-0.016	0.009	-	-0.114	-1.24	-0.234	0.002	-0.018	-0.022	-0.025	-0.026	-0.01	-0.01	-0.048	-0.045	-0.075	-0.088	0.034	0.045	0.017	0.02
Return On Equity, ROE	-0.013	-	-0.051	0.185	-0.043	0.092	0.216	0.204	0.474	0.292	0.768	-95.4	17.7	0.009	-0.315	0.096	-	0.036	0.502	5.84	0.178	-0.796	-0.403	-0.215	-0.214	-0.083	-0.147	-3.17	-0.784	-0.8	-0.711	0.202	0.252	0.084	0.092
Return On Capital Employed, ROCE	0.316	-	-0.299	0.164	0.015	0.053	-0.041	-0.124	0.568	-0.173	-0.241	-0.044	-0.334	0.034	-0.104	0.085	-	0.046	1.04	-0.467	-0.003	0.128	0.136	0.058	0.063	0.047	0.058	-0.034	-0.033	-0.112	-0.094	0.02	0.026	0.049	0.071
Net Income Per Ebt	0.547	-	-1.83	1.03	0.165	1.11	1.02	1.01	1.01	1	0.994	1.01	1.01	-0.458	0.26	0.74	-	0.988	1.05	1.05	-0.045	-1.42	-1.34	23.8	23.8	-2.32	-2.32	0.941	0.941	1.2	1.2	0.668	0.668	0.61	0.61
Ebt Per Ebit	0.03	-	0.07	-0.395	3.42	-2.79	18.9	4.26	7.46	3.21	2.99	2.47	1.65	-0.11	1.15	0.324	-	2.73	1.27	1.27	46.6	0.369	0.439	-0.031	-0.031	0.176	0.176	4.39	4.39	1.79	1.79	4.12	4.12	0.902	0.902
Ebit Per Revenue	0.174	-	-0.115	0.152	0.034	0.029	-0.011	-0.042	-0.105	-0.076	-0.139	-0.044	-0.243	0.029	-0.093	0.067	-	-0.014	-0.655	-0.655	-0.002	0.072	0.139	0.062	0.062	0.042	0.042	-0.013	-0.013	-0.067	-0.067	0.024	0.024	0.049	0.049
Debt Ratio	0.776	0.744	0.828	0.906	0.913	1.41	1.24	1.16	1.69	1.06	0.806	0.589	0.453	0.352	0.484	0.365	0.383	2.76	2.03	0.546	0.491	0.437	0.438	0.674	0.558	0.433	0.345	0.258	0.314	0.364	0.412	0.482	0.471	0.449	0.458
Debt Equity Ratio	-4.99	-5.05	-4.71	-4.46	-8.72	-1.95	-1.72	-2.1	-1.5	-2.1	-2.33	1.02 K	-38.2	4.13	9.52	3.88	-16.8	-0.868	-0.826	-13.7	51	18.9	8.01	5.86	4.64	3.43	4.89	17	5.51	3.89	3.32	2.86	2.64	2.27	2.12
Long Term Debt To Capitalization	2.05	1.98	2.99	1.48	1.23	3.42	8.61	8.71	-2.92	2.96	1.95	0.999	1.03	0.798	0.899	0.767	1.11	-2.39	-1.63	1.2	0.922	0.801	0.567	0.727	0.706	0.68	0.69	0.75	0.379	0.214	0.564	0.679	0.662	0.629	0.501
Total Debt To Capitalization	1.25	1.25	1.27	1.29	1.13	2.06	2.38	1.91	3	1.91	1.75	0.999	1.03	0.805	0.905	0.795	1.06	-6.58	-4.73	1.08	0.981	0.95	0.889	0.854	0.823	0.774	0.83	0.944	0.846	0.795	0.768	0.741	0.725	0.694	0.679
Interest Coverage	-	-	-	-	0.209	0.305	-0.094	-0.343	-	-	-	-	-	-	-	-	-	-	-5.28	-5.28	-	1.03	-	1.0	1.0	0.75	0.75	-0.374	-0.374	-1.47	-1.47	0.743	0.743	0.996	0.996
Cash Flow To Debt Ratio	0.0	-	-	-0.024	0.041	-0.107	0.048	-0.096	-0.064	-0.142	-0.147	-0.242	-0.1	-0.092	0.268	0.025	-	-0.177	-0.487	0.044	0.035	0.043	0.174	-0.076	-0.096	-0.159	-0.199	0.042	0.032	-0.055	-0.057	-0.089	-0.121	-0.061	-0.071
Company Equity Multiplier	-6.43	-6.78	-5.69	-4.92	-9.54	-1.38	-1.38	-1.81	-0.889	-1.98	-2.89	1.73 K	-84.3	11.7	19.7	10.7	-44	-0.314	-0.407	-25	104	43.2	18.3	8.7	8.31	7.93	14.2	65.9	17.5	10.7	8.06	5.95	5.61	5.06	4.62
Receivables Turnover	-	-	4.74	8.11	-	11.5	11.1	13	7.37	5.64	6.37	4.92	11.2	1.57	9.86	7.73	-	138	77.3	1.37	-	-	-1.48 K	-	4.34	2.24	2.22	3.2	6.39	-	6.99	2.42	3.03	2.43	3.02
Payables Turnover	1.55	-	1.44	1.8	1.21	2.41	1.5	1.67	1.45	1.38	1.1	1.03	0.875	0.717	1.09	0.886	-	2.59	1.01	0.744	1	0.923	0.576	1.81	1.67	1.66	1.29	1.66	1.83	1.48	1.85	1.59	2.1	1.75	2.28
Inventory Turn Over	2.34	-	2.39	2.4	1.87	2.7	2.74	2.44	2.37	2.3	2.6	2.05	2.65	1.59	2.81	1.69	-	5.09	2.16	1.6	1.74	1.78	0.939	1.49	1.6	1.85	1.88	3.03	2.66	1.72	2.02	1.58	2.13	1.86	2.34
Fixed Asset Turnover	1.98	-	2.13	1.88	1.14	2.8	2.96	2.22	2.22	28	33.1	23.4	22.7	19.5	15.7	12	-	13.9	6.18	1.24	2.42	3.2	1.79	3.56	3.47	3.5	3.32	4.6	3.87	2.25	2.71	2.35	2.62	1.78	1.92
Asset Turnover	0.714	-	0.615	0.605	0.235	0.74	0.772	0.624	0.674	0.605	0.641	0.504	0.519	0.504	0.578	0.56	-	3.06	1.41	0.268	0.411	0.488	0.27	0.543	0.565	0.61	0.609	0.888	0.825	0.521	0.615	0.52	0.689	0.614	0.734
Operating Cash Flow Sales Ratio	0.0	-	-	-0.036	0.159	-0.204	0.077	-0.178	-0.161	-0.249	-0.185	-0.283	-0.087	-0.064	0.224	0.016	-	-0.16	-0.7	0.09	0.042	0.039	0.282	-0.095	-0.095	-0.113	-0.113	0.012	0.012	-0.038	-0.038	-0.083	-0.083	-0.044	-0.044
Free Cash Flow Operating Cash Flow Ratio	0.724	-	-	1.44	0.82	1.29	0.231	1.14	1.13	1.03	1.06	1.02	1.11	1.11	0.95	1	-	1.01	0.962	0.53	-0.66	-0.693	0.72	1.2	1.2	1.09	1.09	-0.089	-0.089	2.22	2.22	1.71	1.71	2.44	2.44
Cash Flow Coverage Ratios	0.0	-	-	-0.024	0.041	-0.107	0.048	-0.096	-0.064	-0.142	-0.147	-0.242	-0.1	-0.092	0.268	0.025	-	-0.177	-0.487	0.044	0.035	0.043	0.174	-0.076	-0.096	-0.159	-0.199	0.042	0.032	-0.055	-0.057	-0.089	-0.121	-0.061	-0.071
Short Term Coverage Ratios	0.0	-	-	-6.39	0.201	-0.829	0.297	-0.396	-0.193	-0.504	-1.24	-1.61	-0.641	-2.17	3.97	0.167	-	-0.945	-1.96	0.079	0.046	0.055	0.198	-0.27	-0.302	-0.423	-0.371	0.053	0.037	-0.06	-0.095	-0.34	-0.467	-0.24	-0.136
Capital Expenditure Coverage Ratio	3.62	-	-	-2.26	5.55	-3.47	1.3	-6.93	-7.51	-33	-17.9	-63.5	-9.48	-8.71	19.9	-	-	-100	-26.5	2.13	0.603	0.591	3.58	-4.93	-4.93	-11.4	-11.4	0.918	0.918	-0.818	-0.818	-1.41	-1.41	-0.695	-0.695
Dividend Paid And Capex Coverage Ratio	3.62	-	-	-2.26	5.55	-3.47	1.3	-6.93	-7.51	-33	-17.9	-63.5	-9.48	-8.71	19.9	-	-	-100	-26.5	2.13	0.603	0.591	3.58	-4.93	-4.93	-11.4	-11.4	0.918	0.918	-0.818	-0.818	-1.41	-1.41	-0.695	-0.695
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Price To Free Cash Flows Ratio, P/FCF	99.9 K	-	-	-96.9	64.2	-14.1	189	-8.35	-2.93	-2.37	-4.06	-3.26	-4.83	-7.01	4.58	50.4	-	-0.866	-0.612	9.84	-32.2	-	-	-4.9	-4.9	-179	-179	-13.7 K	-13.7 K	-262	-262	-0.422	-0.422	-0.919	-0.919
Price To Operating Cash Flows Ratio, P/OCF	72.3 K	-	-	-140	52.7	-18.1	43.6	-9.56	-3.32	-2.44	-4.29	-3.31	-5.34	-7.82	4.35	50.4	-	-0.875	-0.589	5.21	21.2	-	-	-5.9	-5.9	-195	-195	1.23 K	1.23 K	-582	-582	-0.723	-0.723	-2.24	-2.24
Price Cash Flow Ratio, P/CF	72.3 K	-	-	-140	52.7	-18.1	43.6	-9.56	-3.32	-2.44	-4.29	-3.31	-5.34	-7.82	4.35	50.4	-	-0.875	-0.589	5.21	21.2	-	-	-5.9	-5.9	-195	-195	1.23 K	1.23 K	-582	-582	-0.723	-0.723	-2.24	-2.24
Enterprise Value Multiple, EV	40.9	-	140	117	53.2	45.7	708	32.1	-37.4	-47.5	-18.7	-145	-6.26	29.5	-22.1	17.6	-	-149	-2.57	-3.48	104	7.23	9.33	19.9	17.1	264	262	993	998	-562	-562	6.1	4.57	6.51	5.79
Price Fair Value, P/FV	-15.5	-	-15.9	-15.2	-18.8	-3.77	-3.57	-1.92	-0.322	-0.729	-1.47	817	-20.4	2.96	11.1	4.94	-	-0.134	-0.237	-3.15	37.9	-	-	2.63	2.62	107	190	884	218	125	111	0.185	0.231	0.309	0.338

All numbers in RUB currency

Multiples are an important financial analysis tool for the company Аптеки 36.6, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios

Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Pharmaceutical retailers industry

Issuer	Price	% 24h	Market Cap	Country
BOQI International Medical BIMI	-	6.33 %	$ 5.86 M	China
PetMed Express PETS	$ 1.99	-2.93 %	$ 41.6 M	USA
China Jo-Jo Drugstores, Inc. CJJD	-	-5.59 %	$ 49.9 M	China
111 YI	$ 3.8	-	$ 661 M	China
Trxade Group MEDS	-	4.55 %	$ 5.8 M	USA
Rite Aid Corporation RAD	-	-	$ 35.5 M	USA
Walgreens Boots Alliance WBA	-	-	$ 10.3 B	USA
LifeMD LFMD	$ 3.71	-4.13 %	$ 167 M	USA
Greenlane Holdings GNLN	$ 2.11	0.48 %	$ 15.8 M	USA

Аптеки 36.6 Financial Ratios 2025-2004 | APTK

Brief overview of Аптеки 36.6's valuation and returns

Overall assessment

Annual Financial Ratios Аптеки 36.6

Price Earnings Ratio, P/E

Price Sales Ratio, P/S

Price To Book Ratio, P/B

Price Earnings To Growth Ratio, PEG

Operating Cash Flow Per Share

Free Cash Flow Per Share

Cash Per Share

Payout Ratio

Dividend Yield

Current Ratio

Quick Ratio

Cash Ratio

Days Of Sales Outstanding, DSO

Days Of Inventory Outstanding, DIO

Days Of Payables Outstanding, DPO

Operating Cycle

Cash Conversion Cycle

Gross Profit Margin

Operating Profit Margin

Pretax Profit Margin

Net Profit Margin

Effective Tax Rate

Return On Assets, ROA

Return On Equity, ROE

Return On Capital Employed, ROCE

Net Income Per Ebt

Ebt Per Ebit

Ebit Per Revenue

Debt Ratio

Debt Equity Ratio

Long Term Debt To Capitalization

Total Debt To Capitalization

Interest Coverage

Cash Flow To Debt Ratio

Company Equity Multiplier

Receivables Turnover

Payables Turnover

Inventory Turn Over

Fixed Asset Turnover

Asset Turnover

Operating Cash Flow Sales Ratio

Free Cash Flow Operating Cash Flow Ratio

Cash Flow Coverage Ratios

Short Term Coverage Ratios

Capital Expenditure Coverage Ratio

Dividend Paid And Capex Coverage Ratio

Dividend Payout Ratio

Price To Free Cash Flows Ratio, P/FCF

Price To Operating Cash Flows Ratio, P/OCF

Price Cash Flow Ratio, P/CF

Enterprise Value Multiple, EV

Price Fair Value, P/FV